| Document Type
|
:
|
BL
|
| Record Number
|
:
|
622434
|
| Doc. No
|
:
|
dltt
|
| Title & Author
|
:
|
Cannabinoids in neurologic and mental disease /\ edited by Liana Fattore
|
| Page. NO
|
:
|
xliii, 452 pages :: illustrations ;; 25 cm
|
| ISBN
|
:
|
9780124170414
|
|
|
:
|
: 0124170412
|
|
|
:
|
9780124171244 (eBook)
|
| Bibliographies/Indexes
|
:
|
Includes bibliographical references and index
|
| Contents
|
:
|
Part 1. Role of the Endocannabinoids in Neuroinflammatory and Neurodegenerative Disorders: Cannabinoids for the treatment of neuroinflammation -- Endocannabinoids and Alzheimer's disease -- Cannabinoids in Parkinson's disease -- Cannabinoids in Huntington's disease -- Endocannabinoids and amyotrophic lateral sclerosis -- Endocannabinoids and epilepsy -- Endocannabinoids and migraine -- Part 2. Role of the Endocannabinoids in Psychological and Psychiatric Disorders: Cannabinoids and schizophrenia -- Cannabinoids and bipolar disorder -- Cannabinoids and the Tourette syndrome -- The role of endocannabinoid function in posttraumatic stress disorder: Modulating the risk phenotype and rendering effects of trauma -- Cannabinoids and drug addiction -- Cannabinoids and appetite (dys)regulation -- Part 3. Role of the Endocannabinoids in Impulsive and Compulsive Disorders: The cannabinoid system and impulsive behavior -- Cannabinoids and obsessive-compulsive disorder -- The endocannabinoid system: anorexia nervosa and binge eating disorder -- The endocannabinoid system and trichotillomania: a promising target for treatment -- Future perspectives: Cannabinoid CB2 receptor ligands and their therapeutic potential in mental diseases
|
| Subject
|
:
|
Cannabinoids-- therapeutic use
|
| Subject
|
:
|
Nervous System Diseases-- drug therapy
|
| Subject
|
:
|
Mental Disorders-- drug therapy
|
| NLM classification
|
:
|
2015 E-936
|
|
|
:
|
WL 140
|
| Added Entry
|
:
|
Fattore, Liana
|